• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Inhibitory effects of emodin, baicalin, schizandrin and berberine on hefA gene: treatment of Helicobacter pylori-induced multidrug resistance.大黄素、黄芩苷、五味子素和小檗碱对hefA基因的抑制作用:幽门螺杆菌诱导的多药耐药性的治疗
World J Gastroenterol. 2015 Apr 14;21(14):4225-31. doi: 10.3748/wjg.v21.i14.4225.
2
Efflux pump gene hefA of Helicobacter pylori plays an important role in multidrug resistance.幽门螺杆菌的外排泵基因hefA在多药耐药中起重要作用。
World J Gastroenterol. 2008 Sep 7;14(33):5217-22. doi: 10.3748/wjg.14.5217.
3
The crosstalk between efflux pump and resistance gene mutation in .在... 中,外排泵与耐药基因突变的串扰
Gut Microbes. 2024 Jan-Dec;16(1):2379439. doi: 10.1080/19490976.2024.2379439. Epub 2024 Jul 25.
4
Broad spectrum resistance in Helicobacter pylori isolated from gastric biopsies of patients with dyspepsia in Cameroon and efflux-mediated multiresistance detection in MDR isolates.在喀麦隆消化不良患者的胃活检中分离出的幽门螺杆菌的广谱耐药性和 MDR 分离株中流出介导的多药耐药性检测。
BMC Infect Dis. 2019 Oct 22;19(1):880. doi: 10.1186/s12879-019-4536-8.
5
Transporters HP0939, HP0497, and HP0471 participate in intrinsic multidrug resistance and biofilm formation in Helicobacter pylori by enhancing drug efflux.转运蛋白 HP0939、HP0497 和 HP0471 通过增强药物外排参与幽门螺杆菌固有多重耐药性和生物膜形成。
Helicobacter. 2020 Aug;25(4):e12715. doi: 10.1111/hel.12715. Epub 2020 Jun 16.
6
[Preliminary study on in-vitro induction of antibiotic resistance in Helicobacter pylori strains isolated from children].[儿童幽门螺杆菌分离株体外诱导抗生素耐药性的初步研究]
Zhonghua Er Ke Za Zhi. 2007 Sep;45(9):708-11.
7
Effect of biofilm formation by clinical isolates of on the efflux-mediated resistance to commonly used antibiotics.临床分离株形成生物膜对通过外排介导的对常用抗生素耐药性的影响。 (注:原文中“of”后面缺少具体内容)
World J Gastroenterol. 2017 Feb 21;23(7):1163-1170. doi: 10.3748/wjg.v23.i7.1163.
8
Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey.土耳其西北部幽门螺杆菌菌株对包括左氧氟沙星在内的五种抗生素的耐药性。
Rev Soc Bras Med Trop. 2015 May-Jun;48(3):278-84. doi: 10.1590/0037-8682-0027-2015.
9
Antimicrobial susceptibility of Helicobacter pylori strains isolated from children in Israel.以色列儿童分离的幽门螺杆菌菌株的抗菌药敏性。
J Glob Antimicrob Resist. 2018 Mar;12:175-178. doi: 10.1016/j.jgar.2017.10.004. Epub 2017 Oct 13.
10
Nationwide antibiotic resistance mapping of Helicobacter pylori in Korea: A prospective multicenter study.韩国全国范围内幽门螺杆菌抗生素耐药性的绘图:一项前瞻性多中心研究。
Helicobacter. 2019 Aug;24(4):e12592. doi: 10.1111/hel.12592. Epub 2019 May 20.

引用本文的文献

1
Green Chemistry Within the Circular Bioeconomy to Harness Chestnut Burr Extract's Synergistic Antimicrobial Activity Against .循环生物经济中的绿色化学,以利用栗苞提取物对……的协同抗菌活性
Molecules. 2025 Jan 15;30(2):324. doi: 10.3390/molecules30020324.
2
Efficacy and safety of LiWei capsule in chronic non-atrophic gastritis with erosions: a randomized controlled trial.胃萎胶囊治疗慢性糜烂性非萎缩性胃炎的疗效及安全性:一项随机对照试验
Sci Rep. 2025 Jan 10;15(1):1620. doi: 10.1038/s41598-025-85122-y.
3
Antibacterial activities of anthraquinones: structure-activity relationships and action mechanisms.蒽醌类化合物的抗菌活性:构效关系及作用机制
RSC Med Chem. 2023 Jul 10;14(8):1446-1471. doi: 10.1039/d3md00116d. eCollection 2023 Aug 16.
4
Study of the Effect of Baicalin from on the Gastrointestinal Tract Normoflora and .黄芩苷对肠道正常菌群及 的影响研究。
Int J Mol Sci. 2023 Jul 25;24(15):11906. doi: 10.3390/ijms241511906.
5
Progress in traditional Chinese medicine against chronic gastritis: From chronic non-atrophic gastritis to gastric precancerous lesions.中医治疗慢性胃炎的进展:从慢性非萎缩性胃炎到胃癌前病变
Heliyon. 2023 May 27;9(6):e16764. doi: 10.1016/j.heliyon.2023.e16764. eCollection 2023 Jun.
6
BanXiaXieXin decoction treating gastritis mice with drug-resistant and its mechanism.半夏泻心汤治疗耐药性胃炎的小鼠及其机制。
World J Gastroenterol. 2023 May 14;29(18):2818-2835. doi: 10.3748/wjg.v29.i18.2818.
7
Phytochemicals as Invaluable Sources of Potent Antimicrobial Agents to Combat Antibiotic Resistance.植物化学物质作为对抗抗生素耐药性的强效抗菌剂的宝贵来源。
Life (Basel). 2023 Apr 4;13(4):948. doi: 10.3390/life13040948.
8
A new approach to overcoming antibiotic-resistant bacteria: Traditional Chinese medicine therapy based on the gut microbiota.一种克服抗生素耐药菌的新方法:基于肠道微生物群的中药疗法。
Front Cell Infect Microbiol. 2023 Apr 6;13:1119037. doi: 10.3389/fcimb.2023.1119037. eCollection 2023.
9
Efflux Pump Inhibitors in Controlling Antibiotic Resistance: Outlook under a Heavy Metal Contamination Context.外排泵抑制剂在控制抗生素耐药性方面的作用:重金属污染背景下的展望。
Molecules. 2023 Mar 24;28(7):2912. doi: 10.3390/molecules28072912.
10
A review on the research progress on non-pharmacological therapy of .关于……非药物治疗的研究进展综述
Front Microbiol. 2023 Mar 17;14:1134254. doi: 10.3389/fmicb.2023.1134254. eCollection 2023.

本文引用的文献

1
Anticancer potential of emodin.大黄素的抗癌潜力。
Biomedicine (Taipei). 2012 Sep;2(3):108-116. doi: 10.1016/j.biomed.2012.03.003. Epub 2012 May 11.
2
Therapeutic effects of traditional herbal medicine on cerebral ischemia: a perspective of vascular protection.传统草药对脑缺血的治疗作用:血管保护的视角。
Chin J Integr Med. 2013 Nov;19(11):804-14. doi: 10.1007/s11655-013-1341-2. Epub 2013 Oct 30.
3
Antibiotics resistance rate of Helicobacter pylori in Bhutan.不丹幽门螺杆菌的抗生素耐药率。
World J Gastroenterol. 2013 Sep 7;19(33):5508-12. doi: 10.3748/wjg.v19.i33.5508.
4
Pathogenesis of Helicobacter pylori infection.幽门螺杆菌感染的发病机制。
Helicobacter. 2013 Sep;18 Suppl 1:12-7. doi: 10.1111/hel.12076.
5
Detection of A2142C, A2142G, and A2143G Mutations in 23s rRNA Gene Conferring Resistance to Clarithromycin among Helicobacter pylori Isolates in Kerman, Iran.伊朗克尔曼幽门螺杆菌分离株中23s rRNA基因A2142C、A2142G和A2143G突变与克拉霉素耐药性的检测
Iran J Med Sci. 2011 Jun;36(2):104-10.
6
Helicobacter pylori infection in India from a western perspective.从西方视角看印度的幽门螺杆菌感染。
Indian J Med Res. 2012 Oct;136(4):549-62.
7
Long-term follow-up Helicobacter pylori reinfection rate and its associated factors in Korea.韩国的幽门螺杆菌再感染率及其相关因素的长期随访研究。
Helicobacter. 2013 Apr;18(2):135-42. doi: 10.1111/hel.12018. Epub 2012 Oct 8.
8
[Helicobacter pylori-related diseases].[幽门螺杆菌相关疾病]
Gastroenterol Hepatol. 2012 Sep;35 Suppl 1:12-25. doi: 10.1016/S0210-5705(12)70030-4.
9
[Genotyping of mutations contributing to antibiotic resistance and Helicobacter pylori eradication therapy].
Zhonghua Yi Xue Za Zhi. 2012 Mar 13;92(10):657-8.
10
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.幽门螺杆菌感染的管理——马斯特里赫特 IV/佛罗伦萨共识报告。
Gut. 2012 May;61(5):646-64. doi: 10.1136/gutjnl-2012-302084.

大黄素、黄芩苷、五味子素和小檗碱对hefA基因的抑制作用:幽门螺杆菌诱导的多药耐药性的治疗

Inhibitory effects of emodin, baicalin, schizandrin and berberine on hefA gene: treatment of Helicobacter pylori-induced multidrug resistance.

作者信息

Huang Yan-Qiang, Huang Gan-Rong, Wu Ming-Hui, Tang Hua-Ying, Huang Zan-Song, Zhou Xi-Han, Yu Wen-Qiang, Su Jian-Wei, Mo Xiao-Qiang, Chen Bing-Pu, Zhao Li-Juan, Huang Xiao-Feng, Wei Hong-Yu, Wei Lian-Deng

机构信息

Yan-Qiang Huang, Gan-Rong Huang, Hua-Ying Tang, Xiao-Qiang Mo, Bing-Pu Chen, Li-Juan Zhao, Xiao-Feng Huang, Hong-Yu Wei, Lian-Deng Wei, Department of Medical Microbiology and Immunology, Youjiang Medical College for Nationalities, Baise 533000, Guangxi Zhuang Autonomous Region, China.

出版信息

World J Gastroenterol. 2015 Apr 14;21(14):4225-31. doi: 10.3748/wjg.v21.i14.4225.

DOI:10.3748/wjg.v21.i14.4225
PMID:25892872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4394083/
Abstract

AIM

To investigate the inhibitory effects of emodin, baicalin, etc. on the hefA gene of multidrug resistance (MDR) in Helicobacter pylori (H. pylori).

METHODS

The double dilution method was used to screen MDR H. pylori strains and determine the minimum inhibitory concentrations (MICs) of emodin, baicalin, schizandrin, berberine, clarithromycin, metronidazole, tetracycline, amoxicillin and levofloxacin against H. pylori strains. After the screened MDR stains were treated with emodin, baicalin, schizandrin or berberine at a 1/2 MIC concentration for 48 h, changes in MICs of amoxicillin, tetracycline, levofloxacin, metronidazole and clarithromycin were determined. MDR strains with reduced MICs of amoxicillin were selected to detect the hefA mRNA expression by real-time quantitative PCR.

RESULTS

A total of four MDR H. pylori strains were screened. Treatment with emodin, baicalin, schizandrin and berberine significantly decreased the MICs of amoxicillin and tetracycline against some strains, decreased by 1 to 2 times, but did not significantly change the MICs of clarithromycin, levofloxacin, and metronidazole against MDR strains. In the majority of strains with reduced MICs of amoxicillin, hefA mRNA expression was decreased; one-way ANOVA (SPSS 12.0) used for comparative analysis, P < 0.05.

CONCLUSION

Emodin, baicalin, schizandrin and berberine significantly decreased the MICs of amoxicillin and tetracycline against some H. pylori strains, possibly by mechanisms associated with decreasing hefA mRNA expression.

摘要

目的

研究大黄素、黄芩苷等对幽门螺杆菌(H. pylori)多药耐药(MDR)的hefA基因的抑制作用。

方法

采用双倍稀释法筛选MDR幽门螺杆菌菌株,并测定大黄素、黄芩苷、五味子素、黄连素、克拉霉素、甲硝唑、四环素、阿莫西林和左氧氟沙星对幽门螺杆菌菌株的最低抑菌浓度(MICs)。将筛选出的MDR菌株用1/2 MIC浓度的大黄素、黄芩苷、五味子素或黄连素处理48小时后,测定阿莫西林、四环素、左氧氟沙星、甲硝唑和克拉霉素的MICs变化。选择阿莫西林MICs降低的MDR菌株,通过实时定量PCR检测hefA mRNA表达。

结果

共筛选出4株MDR幽门螺杆菌菌株。大黄素、黄芩苷、五味子素和黄连素处理可使部分菌株的阿莫西林和四环素MICs显著降低,降低1至2倍,但对克拉霉素、左氧氟沙星和甲硝唑对MDR菌株的MICs无显著影响。在大多数阿莫西林MICs降低的菌株中,hefA mRNA表达降低;采用单因素方差分析(SPSS 12.0)进行比较分析,P < 0.05。

结论

大黄素、黄芩苷、五味子素和黄连素可使部分幽门螺杆菌菌株的阿莫西林和四环素MICs显著降低,可能与降低hefA mRNA表达的机制有关。